| Metric | FY 2026 | FY 2025 |
|---|---|---|
| Net income | -34.9 | -26.3 |
| EPS (diluted, $ a share) | $-6.97 | $-62.19 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-K filed with the SEC, NASDAQ: BCTX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
BriaCell Therapeutics Corp.: key numbers
- Share price
- $3.51Close, Nov 17
- Market cap
- $30.7M
- Shares outstanding
- 8.73MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.